MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹18 Cr | ₹9.76 Cr | ₹6.66 Cr | ₹2.64 Cr | ₹0.93 Cr |
What is the latest Contingent Liabilities ratio of MOREPEN LABORATORIES ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹18 Cr |
Mar2024 | ₹9.76 Cr |
Mar2023 | ₹6.66 Cr |
Mar2022 | ₹2.64 Cr |
Mar2021 | ₹0.93 Cr |
How is Contingent Liabilities of MOREPEN LABORATORIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹18 Cr | 87.61 | |
Mar2024 | ₹9.76 Cr | 46.52 | |
Mar2023 | ₹6.66 Cr | 152.33 | |
Mar2022 | ₹2.64 Cr | 184.90 | |
Mar2021 | ₹0.93 Cr | - |
Compare Contingent Liabilities of peers of MOREPEN LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MOREPEN LABORATORIES | ₹2,643.6 Cr | -1.3% | -21.2% | -37.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,498.0 Cr | 1.9% | -2.1% | -6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹165,838.0 Cr | 2.7% | -5.6% | 25.2% | Stock Analytics | |
CIPLA | ₹129,330.0 Cr | 3.4% | 7.7% | 0.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,235.0 Cr | 0.6% | 4.4% | 9.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,211.0 Cr | 3.2% | 1.6% | -8.4% | Stock Analytics |
MOREPEN LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MOREPEN LABORATORIES | -1.3% |
-21.2% |
-37.6% |
SENSEX | 0.5% |
-1.3% |
0.9% |
You may also like the below Video Courses